These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20523864)

  • 21. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
    Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
    Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
    Disertori M; Zeni P; Quintarelli S; Bonmassari R
    G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials.
    Bhuriya R; Singh M; Sethi A; Molnar J; Bahekar A; Singh PP; Khosla S; Arora R
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):178-84. PubMed ID: 21285399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor blockers in the prevention of atrial fibrillation.
    Barra S; Silvestri N; Vitagliano G; Madrid A; Gaeta G
    Expert Opin Pharmacother; 2009 Jun; 10(9):1395-411. PubMed ID: 19466911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.
    Disertori M; Barlera S; Staszewsky L; Latini R; Quintarelli S; Franzosi MG
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):47-54. PubMed ID: 22009136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs.
    Sutanto H; Laudy L; Clerx M; Dobrev D; Crijns HJGM; Heijman J
    Pharmacol Res; 2019 Oct; 148():104444. PubMed ID: 31493513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility.
    Choudhury A; Lip GY
    Expert Opin Investig Drugs; 2004 Jul; 13(7):841-55. PubMed ID: 15212622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
    Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of medical treatment on long-term results after surgical ablation of atrial fibrillation in cardiac surgical patients.
    Feyrer R; Ballazhi F; Seitz T; Weyand M; Harig F
    Ann Thorac Cardiovasc Surg; 2014; 20(3):207-12. PubMed ID: 23558224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting the Role of Antiarrhythmic Drugs in Prevention of Atrial Fibrillation Recurrence: A Single Center Retrospective Review.
    Mascarenhas DA; Sharma M
    Cardiol Res; 2018 Jun; 9(3):165-170. PubMed ID: 29904452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic drugs for atrial fibrillation.
    Marinelli A; Capucci A
    Expert Opin Pharmacother; 2011 Jun; 12(8):1201-15. PubMed ID: 21323608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.